In vitro studies have shown that EBNA-1 transgenic mice develop B cell lymphoma with a very long latency, and EBNA-1 and c-myc may cooperate in its development[2,8]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.